Eosinophil expression of transforming growth factor-beta and its receptors in nasal polyposis: Role of the cytokines in this disease process

被引:23
作者
Eisma, RJ [1 ]
Allen, JS [1 ]
Lafreniere, D [1 ]
Leonard, G [1 ]
Kreutzer, DL [1 ]
机构
[1] UNIV CONNECTICUT, CTR HLTH,DEPT SURG, DIV OTOLARYNGOL HEAD & NECK SURG,SCH MED, FARMINGTON, CT 06030 USA
关键词
D O I
10.1016/S0196-0709(97)90062-4
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Purpose: Nasal polyposis (NP) is characterized by an increase in inflammatory processes including fibrosis. Because transforming growth factor beta (TGF-beta) has been proven to induce fibrosis, we hypothesize that TGF-beta and its receptors ire present in NP and influence polyp development. Materials and Methods: To test this hypothesis, we evaluated distribution (immunohistochemistry) of TGF-beta isoforms (TGF-beta 1, TGF-beta 2, and TGF-beta 3) and its receptors [(TGF-beta(RI) & TGF-beta(RII)] in NP from 36 NP patients and in five normal sinus tissue specimens obtained from septoplasty/inferior turbinectomy. Tissue levels of TGF-beta 1 and TGF-beta 2 levels were determined by enzyme-linked immunosorbent assay (ELISA) and protein content was determined by Bio Rad assay (Bio Rad, Richmond, CA). All tissue levels of TGF-beta were normalized and expressed as pg of TGF-beta per mg of total protein (pg/mg TP). Results: Immunohistochemical studies showed eosinophils as the major cells positively staining for TGF-beta 1, TGF-beta 2, TGF-beta 3, TGF-beta(RI), and TGF-beta. In fibrotic sections, increased staining of eosinophils, fibroblasts, and mononuclear cells was found for all three isoforms and both receptors. Evaluation of tissue levels indicated mean levels for TGF-beta 1 in the NP were 11.64 +/- 22.12 pg/mg TP versus normal control mean 44.36 +/- 22.12 pg/mg TP. TGF-beta 2 mean levels were 11.46 +/- 23.73 pg/mg TP versus normal control mean of 2.03 +/- 1.13 pg/mg TP. NP showed decreased expression of TGF-beta 1 and enhanced expression of TGF-beta 2 isoforms with presence of their receptors. Higher levels of TGF-beta 2 correlated with an increase in previous polypectomies perhaps indicative of severity of disease (P less than or equal to .0001). Conclusion: Our studies show the presence of the TGF-beta isoforms and receptors in NP tissue. The results support our hypothesis that the eosinophil continues to be a pivotal inflammatory cell in NP, a differential regulation may govern the activity of TGF-beta in NP, and hence, the TGF-beta family of cytokines and receptors likely play a key role in controlling NP formation. Copyright (C) 1997 by W.B. Saunders Company.
引用
收藏
页码:405 / 411
页数:7
相关论文
共 16 条
[1]   Interleukin-5, interleukin-5, and granulocyte-macrophage colony-stimulating factor expression in nasal polyps [J].
Allen, JS ;
Eisma, R ;
Leonard, G ;
Kreutzer, D .
AMERICAN JOURNAL OF OTOLARYNGOLOGY, 1997, 18 (04) :239-246
[2]  
ALLEN JS, IN PRESS OTOLARYNGOL
[3]  
Ballenger JJ, 1996, OTORHINOLARYNGOLOGY, P130
[4]   Role of allergy in nasal polyposis: A review [J].
Bernstein, JM ;
Gorfien, J ;
Noble, B .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1995, 113 (06) :724-732
[5]   TRANSFORMING GROWTH-FACTOR-BETA IN DISEASE - THE DARK SIDE OF TISSUE-REPAIR [J].
BORDER, WA ;
RUOSLAHTI, E .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :1-7
[6]   STRUCTURAL CELL-DERIVED CYTOKINES IN ALLERGIC INFLAMMATION [J].
DENBURG, JA ;
GAULDIE, J ;
DOLOVICH, J ;
OHTOSHI, T ;
COX, G ;
JORDANA, M .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1991, 94 (1-4) :127-132
[7]  
EPSTEIN FR, 1994, NEW ENGL J MED, P1286
[8]   MODULATION OF THE IMMUNE-RESPONSE BY TRANSFORMING GROWTH-FACTOR-BETA [J].
FONTANA, A ;
CONSTAM, DB ;
FREI, K ;
MALIPIERO, U ;
PFISTER, HW .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1992, 99 (01) :1-7
[9]   EXPRESSION OF MESSENGER-RNA FOR INTERLEUKIN-5 IN MUCOSAL BRONCHIAL BIOPSIES FROM ASTHMA [J].
HAMID, Q ;
AZZAWI, M ;
YING, S ;
MOQBEL, R ;
WARDLAW, AJ ;
CORRIGAN, CJ ;
BRADLEY, B ;
DURHAM, SR ;
COLLINS, JV ;
JEFFERY, PK ;
QUINT, DJ ;
KAY, AB .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (05) :1541-1546
[10]  
JOSEPHSON JS, 1990, CURRENT THERAPY OTOL, V4, P287